Healthcare -
Biotechnology - NASDAQ - US
$ 10.88
-0.548 %
$ 594 M
Market Cap
13.27
P/E
STOK - COST OF REVENUE
Cost of Revenue STOK - Stoke Therapeutics, Inc.
4.44 M
LAST VALUE
12.10%
2 YEAR CAGR
58.08%
5 YEAR CAGR
0.00%
10 YEAR CAGR